SourceBio International Resolves PCR Testing Dispute With UK's Tax Office
21 9월 2022 - 4:44PM
Dow Jones News
By Sabela Ojea
SourceBio International PLC said Wednesday that it has resolved
its dispute with the U.K.'s tax office on treating the accounting
for Covid-19 PCR services as value-added tax exempt.
The U.K. provider of laboratory services said it has received
written confirmation from the U.K.'s HM Revenue & Customs on
the acceptance of SourceBio's VAT position.
In December 2021, the U.K.'s tax office issued a letter that
challenged the group's VAT treatment of PCR testing services
provided.
"HMRC suggested that some of those services should have been
treated as standard rated for VAT purposes," SourceBio said.
Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix
(END) Dow Jones Newswires
September 21, 2022 03:29 ET (07:29 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
Sourcebio (LSE:SBI)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Sourcebio (LSE:SBI)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024
Sourcebio International Plc (London Stock Exchange)의 실시간 뉴스: 최근 기사 0
More Sourcebio International Plc News Articles